Avandia resource center
Avandia (rosiglitazone) for the treatment of type 2 diabetes, is the most widely studied oral anti-diabetic medicine, with experience in over 52,000 patients worldwide.
Extensive clinical data have shown it to be safe and effective when used appropriately, in accordance with labelling.
- Visit Avandia resource center
- Visit Avandia.com for products information
Announcements
Recent headlines
[an error occurred while processing this directive]
[an error occurred while processing this directive]
July 26, 2010
GlaxoSmithKline to Implement New Compensation Program for U.S. Sales Professionals
July 21, 2010
GlaxoSmithKline statement in response to FDA announcement on TIDE trial
July 21, 2010
GSK announces Q2 results for 2010
GSK News Services
Leading the way to make clinical trial data more transparent
Learn about flu treatment
Find health information
Save money on your prescriptions
Join GSK
Updated July 30, 2010
© 2001 - 2010 GlaxoSmithKline - All rights reserved